Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H26N2O3 |
| Molecular Weight | 342.432 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NOC(CCCCCCCOC2=CC=C(C=C2)C3=NCCO3)=C1
InChI
InChIKey=FKLJPTJMIBLJAV-UHFFFAOYSA-N
InChI=1S/C20H26N2O3/c1-16-15-19(25-22-16)7-5-3-2-4-6-13-23-18-10-8-17(9-11-18)20-21-12-14-24-20/h8-11,15H,2-7,12-14H2,1H3
| Molecular Formula | C20H26N2O3 |
| Molecular Weight | 342.432 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Disoxaril is the antipicornavirus drug. It is an isoxazole heterocyclic compound and a member of the antiviral series commonly referred to as WIN compounds. Disoxaril inhibits enterovirus replication by binding to the hydrophobic pocket within the VP1 coat protein, thus stabilizing the virion and blocking its uncoating. The amino acid sequence of a large VP1 196-258 peptide (disoxaril-binding region) of CVB1/RESISTANT was significantly different from that of the CVB1/SOF (sensitive). Crucially important changes in CVB1/RES were two point mutations, M213H and F237L, both in the ligand-binding pocket. Treatment with disoxaril in newborn mice infected with Coxsackie B1 virus, for 10 days post virus inoculation decreased the virus titer in the mouse brain till day 7.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Imaging poliovirus entry in live cells. | 2007-07 |
|
| A scalable machine-learning approach to recognize chemical names within large text databases. | 2006-09-06 |
|
| Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies. | 2006-02 |
|
| Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. | 2005-07 |
|
| Synergistic drug combinations against the in vitro replication of Coxsackie B1 virus. | 2004-04 |
|
| Development of resistance to disoxaril in Coxsackie B1 virus-infected newborn mice. | 2003-09 |
|
| [[[(Thienylcarbonyl)alkyl]oxy]phenyl]- and [[[(pyrrylcarbonyl)alkyl]oxy]phenyl]oxazoline derivatives with potent and selective antihuman rhinovirus activity. | 1995-03-03 |
|
| Human rhinovirus 14 complexed with fragments of active antiviral compounds. | 1994-07 |
|
| A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program. | 1991-10 |
|
| A model for compounds active against human rhinovirus-14 based on X-ray crystallography data. | 1990-05 |
|
| Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides. | 1990-02 |
|
| Enantiomeric effects of homologues of disoxaril on the inhibitory activity against human rhinovirus-14. | 1988-03 |
|
| Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating. | 1987-02 |
|
| The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. | 1986-09-19 |
|
| Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. | 1986-07 |
|
| Oral efficacy of WIN 51711 in mice infected with human poliovirus. | 1986-01 |
|
| [[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating. | 1985-12 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:36:14 GMT 2025
by
admin
on
Wed Apr 02 07:36:14 GMT 2025
|
| Record UNII |
FX8Q9PI4VP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C281
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000081097
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
PRIMARY | |||
|
C045978
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
PRIMARY | |||
|
55717
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
PRIMARY | |||
|
CHEMBL283639
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
PRIMARY | |||
|
87495-31-6
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
PRIMARY | |||
|
5919
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
PRIMARY | |||
|
DTXSID70236354
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
PRIMARY | |||
|
W-27
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
PRIMARY | |||
|
FX8Q9PI4VP
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
PRIMARY | |||
|
SUB06322MIG
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
PRIMARY | |||
|
C81607
Created by
admin on Wed Apr 02 07:36:14 GMT 2025 , Edited by admin on Wed Apr 02 07:36:14 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
